retatrutide mercado libre 10mg Retatrutide | MercadoLibre
Description
The injectable drug, initially only used as diabetes medication, is the first drug since Saxenda (2014) approved to treat chronic weight management in the 70% of American adults who are obese or overweight.
The Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market worth USD 10.49 billion in 2026 is growing at a CAGR of 4.27% to reach USD 12.93 billion by 2031
The state insurance board voted to eliminate GLP-1 weight loss drug coverage for thousands of public workers.
| Big-box retailer Costco is expanding its reach into healthcare services with a new weight loss program for members.
